Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMA110 topical gel versus podophyllin for genital warts
IRCT20181026041466N6Phase 2Completed
- Sponsor
- Rayka Raya Teb
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of podophyllin in anogenital warts (2 arms), sponsored by Rayka Raya Teb. Primary endpoints: Side effects, Size of the lesions and 1 more. Started May 2021; status: completed.
02
Drugs
podophyllin
03
Conditions
anogenital warts
Beyond the preview
Go deeper on IRCT20181026041466N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181026041466N6.